跳至主要内容
临床试验/NCT05766995
NCT05766995已完成不适用

Efficacy of Three Oral Self-care Regimens on Clinical Parameters of Inflammation and Plaque: Part 1 - a Four Week Randomized Controlled Trial

Water Pik, Inc.2 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2021年8月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
105
试验地点
2
主要终点
Bleeding on probing

研究概览

简要总结

To compare three different oral hygiene regimens on changes in gum tissue appearance, gum bleeding, and plaque scores.

详细描述

The goal of this clinical trial was to compare the effect of different battery powered water in and adult population with mild to moderate gingivitis. The main questions it aims to answer are:

  • Is there a difference between the two water flosser devices on gum bleeding scores?
  • Is there a difference between the two water flosser devices on plaque accumulation and removal?
  • Is there a difference between the two water flosser devices on signs of gingivitis?

Researchers will compare the two groups using a water flosser (experimental) to see how it compares to traditional brushing and flossing (control).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have provided written informed consent prior to being entered into the study.
  • Be between 18 and 75 years of age, male or female.
  • Have at least twenty (20) natural teeth (5 evaluable in each quadrant) with scorable facial and lingual surfaces as determined by the clinical examiner.
  • Nonsmoking (assessed as < 1 cigarette every day for at least a year).
  • Have a mean baseline plaque index score of ≥0.60 as determined by the Rustogi Modification of the Navy Plaque Index (RMNPI).
  • Have a mean baseline gingival index score of ≥1.75 as determined by the Modified Gingival Index (MGI).
  • Have a mean bleeding on probing score of 50%.
  • Have probe readings ≤4 mm.
  • Agree not to have a dental prophylaxis or any other elective, non-emergency dental procedures any time during the study.
  • Agree to abstain from the use of chewing gum, mouth rinses, any toothpaste other than the study toothpaste, tooth whitening products (either professional or at home use) and all other oral hygiene other than the study procedures for the duration of the study.
  • Agree to refrain from all oral hygiene on the morning of each evaluation visit and to refrain from eating, drinking or chewing gum for 4 hours prior to each evaluation visit.
  • Agree to comply with the conditions and schedule of the study.

排除标准

  • Physical limitations or restrictions that might preclude normal use of devices.
  • Evidence of gross oral pathology, including widespread caries or chronic neglect, extensive restoration, pre-existing gross plaque or soft or hard tissue tumor of the oral cavity.
  • Supra- or subgingival calculus that might interfere with evaluations as determined by the clinical examiner.
  • Evidence of major oral hard or soft tissue lesions or trauma at the baseline visit as determined by the clinical examiner.
  • Conditions requiring antibiotic treatment prior to dental procedures.
  • History of uncontrolled diabetes or hepatic or renal disease, or other serious conditions or transmittable disease, (e.g. COVID-19, AIDS).
  • Subjects with grossly carious, fully crowned, or extensively restored teeth, orthodontic appliances, peri/oral piercings, or removable partial dentures.
  • Treatment with antibiotics within the 1-month period before the baseline examination, or a condition that is likely to require antibiotic treatment over the course of the trial.
  • Chronic treatment (2-weeks or more) with any medication known to affect periodontal status (including phenytoin, calcium antagonists, cyclosporine, Coumadin, nonsteroidal anti-inflammatory drugs, and aspirin (325 mg)) within 1- month of the baseline examination. All other medications for chronic medical conditions must have been initiated at least 3 months before enrollment.
  • Have moderate to severe periodontal disease or being actively treated for periodontal disease.
  • Concomitant periodontal therapy other than prophylaxis in the last 6 months.
  • Professional prophylaxis within 1 month prior to the baseline clinical evaluation.
  • Subjects who participate in a gingivitis study in the past month.
  • History of significant adverse event following use of oral hygiene products such as toothpastes and mouth rinses.
  • Subjects who are allergic to any ingredients in Crest® Cavity Protection or Colgate® Cavity Protection toothpaste.
  • Self-reported pregnancy or lactating women since hormonal changes can exaggerate gingival response to dental plaque.

结局指标

主要结局

Bleeding on probing

时间窗: 4 weeks

Bleeding recorded on 6 sites per tooth within 30 seconds of instrumentation. 0 = no bleeding, 1= bleeding. Bleeding determined by number of sites bleeding divided by total number of sites = percent bleeding

次要结局

  • Modified gingival index(4 weeks)
  • Rustogi Modification of Navy Plaque Index(4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验